Form 13-F position report

PROTEON THERAPEUTICS INC

Reported by Raymond James Financial Services Advisors Inc

TARA CUSIP 74371L109 Manager CIK 0001462284

Reported 0 shares, down 11,500 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2019
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 10 Through Q3 2019

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for PROTEON THERAPEUTICS INC held by Raymond James Financial Services Advisors Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

23 managers reported PROTEON THERAPEUTICS INC for Q3 2019.

Managers reporting PROTEON THERAPEUTICS INC in Q3 2019.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Abingworth LLP Unchanged 2,017,872 0 0.33% $525,000 20 qtrs
DEERFIELD MANAGEMENT COMPANY L P SERIES C Unchanged 1,224,899 0 0.01% $318,000 20 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 767,422 +64,500 < 0.01% $200,000 12 qtrs
Deer VII & Co Ltd Unchanged 315,101 0 0.09% $82,000 20 qtrs
WEDBUSH SECURITIES INC Added 166,472 +62,472 < 0.01% $43,000 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Unchanged 155,689 0 < 0.01% $40,000 20 qtrs
Virtu Financial LLC New 90,376 +90,376 < 0.01% $23,000 1 qtr
VANGUARD GROUP INC Unchanged 88,184 0 < 0.01% $23,000 20 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP New 76,032 +76,032 < 0.01% $20,000 1 qtr
BOOTHBAY FUND MANAGEMENT LLC New 57,600 +57,600 < 0.01% $15,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2019
Filed
November 07, 2019
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.